 | ||||
RECAP is a rollover extension study of pirfenidone for patients with idiopathic pulmonary fibrosis (IPF) who completed the CAPACITY trials, an investigational program consisting of two large phase 3 trials. This trial is now closed to enrollment. Please explore our site for more information. |
||||
If you need further information regarding these trials
please call the InterMune Medical Information Department at 1-888-486-6411 (1-888-ITMN-411).
The information on this website concerns an investigational medication that has not been approved by the Food and Drug Administration.
©2010 InterMune, Inc.